共 50 条
- [41] An in-progress phase 2 window of opportunity (WOO) trial of targeted therapy with erdafitinib for patients with recurrent FGFR3-altered non-muscle-invasive bladder cancer (NMIBC).JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)DSouza, NeetaGaffney, ChristopherHernandez, ChristianMoran, PatriciaWorth, KaraMcCarter, Melissade Jesus, Manuel R.Solit, David B.Sarungbam, JudyAl-Ahmadie, Hikmat A.Bochner, Bernard H.Iyer, GopaRosenberg, Jonathan E.Pietzak, Eugene J.
- [42] Phase 2 study of the efficacy and safety of erdafitinib in patients (pts) with bacillus Calmette-Guerin (BCG)-unresponsive, high-risk non-muscle-invasive bladder cancer (HRNMIBC) with FGFR3/2 alterations (alt) in THOR-2: Cohort 2 interim analysis results.JOURNAL OF CLINICAL ONCOLOGY, 2023, 41Catto, James W. F.Ben TranMaster, Viraj A.Roupret, MorganPignot, GeraldineTubaro, AndreaShimizu, NobuakiVasdev, NikhilGschwend, Jurgen E.Loriot, YohannNishiyama, HiroyukiRedorta, JoanDaneshmand, SiamakMiura, YujiNaini, VahidCrow, LaurenTriantos, SpyrosBaig, MahadiSteinberg, Gary D.
- [43] Intracutaneous and Intravesical Immunotherapy With Keyhole Limpet Hemocyanin Compared With Intravesical Mitomycin in Patients With Non-Muscle-Invasive Bladder Cancer: Results From a Prospective Randomized Phase III TrialJOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (18) : 2273 - 2279Lammers, Rianne J. M.Witjes, Wim P. J.Janzing-Pastors, Maria H. D.Caris, Christien T. M.Witjes, J. Alfred
- [44] The Safety, Tolerability, and Preliminary Efficacy of a Gemcitabine-releasing Intravesical System (TAR-200) in American Urological Association-defined Intermediate-risk Non-muscle-invasive Bladder Cancer Patients: A Phase 1b StudyEUROPEAN JOURNAL OF OPERATIONAL RESEARCH, 2024, 62 (01) : 8 - 15van Valenberg, F. Johannes P.van der Heijden, Antoine G.Cutie, Christopher J.Bhanvadia, SumeetKeegan, Kirk A.Hampras, ShalakaSweiti, HusseinMaffeo, John C.Jin, ShuChau, AlbertReynolds, Donald L.Iarossi, CrystiKelley, AprilLi, XiangStromberg, Katharine A.Sedelaar, J. P. MichielSteenbruggen, Jessica J. O.Somford, Diederik M.Witjes, J. Alfred
- [45] Systematic Review of the Therapeutic Efficacy of Bladder-preserving Treatments for Non-muscle-invasive Bladder Cancer Following Intravesical Bacillus Calmette-GuerinEUROPEAN UROLOGY, 2020, 78 (03) : 387 - 399Li, RogerSundi, DebasishZhang, JingsongKim, YoungchulSylvester, Richard J.Spiess, Philippe E.Poch, Michael A.Sexton, Wade J.Black, Peter C.Mckiernan, James M.Steinberg, Gary D.Kamt, Ashish M.Gilbert, Scott M.
- [46] Efficacy of intravesical therapies on the prevention of recurrence and progression of non-muscle-invasive bladder cancer: A systematic review and network meta-analysisCANCER MEDICINE, 2020, 9 (21): : 7800 - 7809Lu, Jun-LinXia, Qi-DongLu, Ying-HongLiu, ZhengZhou, PengHu, Heng-LongWang, Shao-Gang
- [47] Efficacy of Intra-Arterial Plus Intravesical Chemotherapy for High-Risk Non-Muscle-Invasive Bladder Cancer: A Pooled AnalysisFRONTIERS IN PHARMACOLOGY, 2021, 12Cheng, ChunliangQiu, DongxuChen, JinboZu, XiongbingLiu, JinhuiLi, HuihuangHu, JiaoYi, ZhenglinHe, TongchenChen, ZhiCui, Yu
- [48] Efficacy of intravesical therapies on the prevention of recurrence and progression of non-muscle-invasive bladder cancer: A systematic review and network meta-analysisEUROPEAN UROLOGY, 2021, 79 : S1066 - S1067Xia, Q-D.Lu, J-L.Hu, J.Hu, H-L.Sun, J-X.Liu, C-Q.Xu, J-Z.Wang, S-G.
- [49] Adjuvant Intravesical Bacillus Calmette-Guerin Therapy and Survival Among Elderly Patients With Non-Muscle-Invasive Bladder CancerJOURNAL OF ONCOLOGY PRACTICE, 2013, 9 (02) : 92 - +Spencer, Benjamin A.McBride, Russell B.Hershman, Dawn L.Buono, DonnaHerr, Harry W.Benson, Mitchell C.Gupta-Mohile, SupriyaNeugut, Alfred I.
- [50] Evaluating the efficacy and safety of intravesical chemotherapies for non-muscle invasive bladder cancer: a network meta-analysisONCOTARGET, 2016, 7 (50) : 82567 - 82579Zhuo, ChuanjunLi, XubinZhuang, HongqingTian, ShunliCui, HailongJiang, RonghuanLiu, ChuanxinTao, RanLin, Xiaodong